Akèy › Epidermolysis Bullosa Dystrophica › Kalifòni
Etid klinik pou Epidermolysis Bullosa Dystrophica nan Kalifòni
7 etid pou Epidermolysis Bullosa Dystrophica ap chèche patisipan nan sit nan Kalifòni.
Vil nan Kalifòni
Tèks ofisyèl etid la (Anglè)
A Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez
- Lucile Packard Children's Hospital, Palo Alto
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 28, 2026 · NCT06423573A Long-Term Safety Follow-up Registry for Patients Who Received Treatment With Prademagene Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) in the Post-Marketing Setting
- Lucile Packard Children's Hospital, Palo Alto
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 14, 2026 · NCT07700966Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa
- Stanford University, Redwood City
Ap rekriteFaz 1/2
Laj 6 ak plis · Tout sèks · Mizajou May 5, 2026 · NCT06834035Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa
- Stanford University School of Medicine, Stanford
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Apr 24, 2026 · NCT01019148A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa
- Mission Dermatology Center, Rancho Santa Margarita
Ap rekriteFaz 3
6 Months · Tout sèks · Mizajou Mar 12, 2026 · NCT07016750MSC EVs in Dystrophic Epidermolysis Bullosa
- USC /Norris Comprehensive Cancer Center University of Southern California, Los Angeles
Ap rekriteFaz 1/2
6 Months · Tout sèks · Mizajou Jun 25, 2025 · NCT04173650Long-Term Follow-up Protocol
- Mission Dermatology Center, Rancho Santa Margarita
- Stanford University, Redwood City
Ap rekriteEtid obsèvasyon
6 Months · Tout sèks · Mizajou Jun 8, 2021 · NCT04917887Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.